Neogen Corporation reports developments tied to its food safety and animal safety businesses, including diagnostic tests, environmental monitoring products, veterinary products and related manufacturing operations. Company updates commonly cover foodborne pathogen detection, Listeria testing, AOAC method certification, Petrifilm manufacturing activity, and product quality or recall matters involving animal health products.
Neogen news also includes quarterly operating results, segment performance in Food Safety and Animal Safety, business transformation updates, leadership and compliance appointments, and governance matters. Its recurring disclosures connect scientific validation, manufacturing execution, customer markets and regulatory interactions across food safety, livestock, and pet health and wellness applications.
NEOGEN Corporation (NASDAQ: NEOG) has launched the enhanced AccuPoint® Advanced sanitation monitoring system, designed for user-friendly operation and improved result analysis. This new generation system features a modern handheld device with an ergonomic design, Wi-Fi connectivity for secure data transfer, and a photodiode multiplier lens for precise measurements. The AccuPoint Advanced NG is the only system that utilizes a flat tip sampler for effective ATP recovery and incorporates RFID technology for efficient testing. This system is recognized as a gold standard in sanitation monitoring within food production facilities.
NEOGEN Corporation (NASDAQ: NEOG) has launched its NEOGEN Analytics environmental monitoring program (EMP) for food and beverage manufacturers, offering a full year of service at no cost. The EMP facilitates remote monitoring, automates reporting, and enhances food safety compliance. This initiative is in response to increased demands for transparency in food safety, accelerated by the COVID-19 pandemic. The program aims to eliminate manual data entry errors and improve operational efficiencies, ultimately providing better resource allocation and increased customer satisfaction.
NEOGEN Corporation (NASDAQ: NEOG) announced a $25,000 donation to the National FFA Organization following the conclusion of their sponsorship agreement. This contribution aims to support agricultural education and combat COVID-19. NEOGEN's CEO, John Adent, emphasized the importance of fostering the future leaders in agriculture. The National FFA Organization, with over 760,000 members, is dedicated to developing student leadership through agricultural education. NEOGEN specializes in food and animal safety products.
Neogen Corporation reported a 17% increase in Q3 revenues, totaling $116.7 million, compared to $99.9 million last year. Year-to-date revenues rose 10% to $341.0 million. Net income for Q3 reached $13.4 million, up 10% from $12.2 million, with EPS at $0.25, compared to $0.23 a year ago. The company noted strong performance in its Food Safety segment, boosted by product line growth and international acquisitions. However, earnings were impacted by $2 million in non-recurring expenses related to unsuccessful acquisitions and lower interest income.
Neogen Corporation (NASDAQ: NEOG) announced the retirement of G. Bruce Papesh from its Board of Directors after 27 years of service. Papesh played a significant role in guiding the company from $8 million in annual revenues to $418 million as of May 31 in the latest fiscal year. His investment expertise was crucial during Neogen's early struggles and subsequent growth. The current Board now includes James Borel, John Adent, and six others. Neogen specializes in food and animal safety products, offering diagnostic test kits and healthcare solutions.
Neogen Corporation (NASDAQ: NEOG) has launched Early Warning™ COVID-19 Testing for wastewater, aimed at detecting SARS-CoV-2 in sludge from wastewater facilities. This reliable test provides quick results to identify outbreaks and potential infections, supporting public health initiatives. CEO John Adent emphasized its importance for communities and industries to maintain safety during the pandemic. The test, developed with RAIN Incubator, allows for targeted responses in areas with high viral loads, thereby reducing transmission risks. Neogen also offers disinfectants and sanitizers to combat COVID-19.
Neogen Corporation (NASDAQ: NEOG) has relaunched its ThyroKare™ (levothyroxine sodium tablets) for dogs, approved by the FDA for treating hypothyroidism, a common endocrine disorder affecting over 5% of dogs. While hypothyroidism is incurable, daily ThyroKare therapy enables dogs to lead normal lives. Neogen's CEO, John Adent, expressed enthusiasm for this product's return, which adds to their expanding range of animal treatment offerings. ThyroKare is available in various strengths and counts, complementing other veterinary products by Neogen.
Neogen Corporation (NASDAQ: NEOG) has introduced a new rapid test called Reveal® Q+ for Aflatoxin M1, capable of detecting this cancer-causing toxin in milk at levels as low as 150 parts per trillion (ppt). This innovative test simplifies the detection process for dairy processors by being compatible with the Raptor® Integrated Analysis Platform, which allows for simultaneous testing of aflatoxin M1 and various dairy antibiotics. Aflatoxin M1 is regulated in many countries, including the U.S. and Brazil, with a threshold of 500 ppt.
Neogen Corporation has acquired Megazyme, Ltd., a leading supplier of analytical solutions for the food and beverage industries, based in Ireland. This acquisition aims to enhance Neogen's food diagnostics portfolio, leveraging Megazyme's innovative methodologies in carbohydrate and enzyme analysis. Megazyme will operate independently under Neogen's European division in Scotland, with Dr. Barry McCleary, Megazyme's CEO, serving as a strategic advisor. The terms of the agreement were not disclosed, but this move strengthens Neogen's position among major food producers.
Neogen Corporation (NASDAQ: NEOG) reported a 7% revenue increase to $115 million for Q2 FY2021, up from $107.8 million last year. Year-to-date revenues reached $224.3 million, also up 7%. Net income for Q2 was $15.9 million, down from $16.3 million, with earnings per share at $0.30. Despite a 13% sales increase in the animal safety segment, gross margin fell to 46.3% due to a shift in product mix. The food safety segment saw a 1% revenue rise, bolstered by new product launches. However, currency headwinds and COVID-19 disruptions impacted performance.